A5085732041- Cancer Immunotherapy and Biomarkers
- Glioma Diagnosis and Treatment
- Immunotherapy and Immune Responses
- Immune cells in cancer
- Immune Cell Function and Interaction
- Ferroptosis and cancer prognosis
- Peroxisome Proliferator-Activated Receptors
- Phagocytosis and Immune Regulation
- Adipokines, Inflammation, and Metabolic Diseases
- Cancer, Hypoxia, and Metabolism
- Biochemical and Molecular Research
- CAR-T cell therapy research
- Adipose Tissue and Metabolism
- T-cell and B-cell Immunology
- Fibroblast Growth Factor Research
- Diabetes and associated disorders
- Acute Lymphoblastic Leukemia research
- Tryptophan and brain disorders
- Endoplasmic Reticulum Stress and Disease
- Neuroinflammation and Neurodegeneration Mechanisms
Nationwide Children's Hospital
2024-2025
The Ohio State University
2025
Beth Israel Deaconess Medical Center
2021-2024
Harvard University
2021-2024
Hadassah Medical Center
2022-2024
Cancer Research Institute
2023
Cornell University
2022
The composition of the tumor immune microenvironment (TIME) is considered a key determinant patients' response to immunotherapy. mechanisms underlying TIME formation and development over time are poorly understood. Glioblastoma (GBM) lethal primary brain cancer for which there no curative treatments. GBMs immunologically heterogeneous impervious checkpoint blockade immunotherapies. Utilizing clinically relevant genetic mouse models GBM, we identified distinct landscapes associated with...
<div>Abstract<p>The composition of the tumor immune microenvironment (TIME) is considered a key determinant patients’ response to immunotherapy. The mechanisms underlying TIME formation and development over time are poorly understood. Glioblastoma (GBM) lethal primary brain cancer for which there no curative treatments. GBMs immunologically heterogeneous impervious checkpoint blockade immunotherapies. Utilizing clinically relevant genetic mouse models GBM, we identified distinct...
<p>Supplementary Table 1</p>
<p>Supplementary table 2</p>
<p>Supplementary table 2</p>
<p>Supplementary Table 1</p>
<p>supplementary figures & legends</p>
<p>supplementary figures & legends</p>
<p>supplementary figures & legends</p>
<p>supplementary figures & legends</p>
<p>Supplementary table 2</p>
<p>Supplementary Table 1</p>
<p>Supplementary Table 1</p>
<p>Supplementary table 2</p>
<p>Supplementary table 2</p>
<div>Abstract<p>The composition of the tumor immune microenvironment (TIME) is considered a key determinant patients’ response to immunotherapy. The mechanisms underlying TIME formation and development over time are poorly understood. Glioblastoma (GBM) lethal primary brain cancer for which there no curative treatments. GBMs immunologically heterogeneous impervious checkpoint blockade immunotherapies. Utilizing clinically relevant genetic mouse models GBM, we identified distinct...
<p>supplementary figures & legends</p>